Diagnosis

Researchers at the Technical University of Munich have discovered they can predict drug resistance in patients with advanced prostate cancer using a new blood test. Read the article here.

Researchers are developing genetic tests, imaging tests, and algorithms like those in face-recognition software in an effort to reduce the 1 million US men a year who have prostate biopsies and, even more important, reduce the thousands who get treatment they don’t need. Read the article here.

A pilot study at the Sunnybrook Health Sciences Centre determined the feasibility of using multiparametric prostate magnetic resonance imaging as the primary screening test for prostate cancer. Initial results showed that prostate magnetic resonance imaging was better to predict prostate cancer than prostate specific antigen in an unselected sample of the general population. Read the article here.

A new paper looks at how MRI and a clear understanding of the functional anatomy around the prostate can allow radiation oncologists to plan a course of treatment for patients with prostate cancer that spares these critical structures. Read the article.

Every four minutes, prostate cancer kills someone, somewhere around the world. Researchers at Cambridge Oncometrix, are developing a simple test that will detect the disease early. Dmitry Soloviev is one the scientists who’s helping to develop a test that can indicate the presence of cancer cells. Dr. Dmitry is the principal scientist at Oncometrix. Watch his video and learn more about this innovative test and how scientists are working to develop it further. Read the article.